CLINICAL_TRIALS
trial_result
· 2021-04-30
Clinical Trial Update: A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis [Phase 2]
Summary
Phase 2 dose-finding study of OPC-6535 in active ulcerative colitis has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Colitis, Ulcerative | Phase 2 | Status: TERMINATED | Results posted: 2021-04-30